[
  {
    "ts": null,
    "headline": "GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo",
    "summary": "Gilead shares slip after CVS refused to add its new HIV drug, Yeztugo, while its Kite unit struck a $350 million deal with Interius BioTherapeutics.",
    "url": "https://finnhub.io/api/news?id=a498c619af8f2bed41761b4d2d3b6a62cd6625a5090c7b45ab77ed435996c623",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755870900,
      "headline": "GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo",
      "id": 136479014,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead shares slip after CVS refused to add its new HIV drug, Yeztugo, while its Kite unit struck a $350 million deal with Interius BioTherapeutics.",
      "url": "https://finnhub.io/api/news?id=a498c619af8f2bed41761b4d2d3b6a62cd6625a5090c7b45ab77ed435996c623"
    }
  },
  {
    "ts": null,
    "headline": "Suze Orman reveals her favorite stock right now and the investing mistake that shaped her strategy",
    "summary": "Suze Orman reveals her favorite stock right now and the investing mistake that shaped her strategy",
    "url": "https://finnhub.io/api/news?id=03c9e876a9f29d950a1dfa70089118437b7e02856f9547f278c249c14c0797fb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755870060,
      "headline": "Suze Orman reveals her favorite stock right now and the investing mistake that shaped her strategy",
      "id": 136487722,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Suze Orman reveals her favorite stock right now and the investing mistake that shaped her strategy",
      "url": "https://finnhub.io/api/news?id=03c9e876a9f29d950a1dfa70089118437b7e02856f9547f278c249c14c0797fb"
    }
  },
  {
    "ts": null,
    "headline": "This Overlooked Biotech Stock Is a Buy for Its Hidden Strengths",
    "summary": "This biotech giant has hidden strengths that could unlock long-term upside.",
    "url": "https://finnhub.io/api/news?id=a679131e51909c4e6256eef6983289b35558b3b850666973ea68e4254a0d3be8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755862202,
      "headline": "This Overlooked Biotech Stock Is a Buy for Its Hidden Strengths",
      "id": 136479015,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "This biotech giant has hidden strengths that could unlock long-term upside.",
      "url": "https://finnhub.io/api/news?id=a679131e51909c4e6256eef6983289b35558b3b850666973ea68e4254a0d3be8"
    }
  },
  {
    "ts": null,
    "headline": "Gilead’s Kite scoops in vivo CAR-T specialist Interius for $350m",
    "summary": "Gilead will integrate Interius, the first biotech to push an in vivo CAR-T therapy into the clinic, into its cell therapy subsidiary Kite.",
    "url": "https://finnhub.io/api/news?id=db31bd700cba8990071aa82bda93b2898abf8070ff674d51178c7546116ae488",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755860016,
      "headline": "Gilead’s Kite scoops in vivo CAR-T specialist Interius for $350m",
      "id": 136476810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead will integrate Interius, the first biotech to push an in vivo CAR-T therapy into the clinic, into its cell therapy subsidiary Kite.",
      "url": "https://finnhub.io/api/news?id=db31bd700cba8990071aa82bda93b2898abf8070ff674d51178c7546116ae488"
    }
  },
  {
    "ts": null,
    "headline": "Top 5 Dividend Stocks For Steady Income",
    "summary": "Indexes hit highs on Fed cut hopes, but inflation risks and FOMC tensions loom. Consider five dividend stocks for steady income amid uncertainty. See more here.",
    "url": "https://finnhub.io/api/news?id=74188dfc6c054335e28cfe325104cfd59c9ce3309ebc27b0a515b2404736c303",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755838800,
      "headline": "Top 5 Dividend Stocks For Steady Income",
      "id": 136475190,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2177695823/image_2177695823.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Indexes hit highs on Fed cut hopes, but inflation risks and FOMC tensions loom. Consider five dividend stocks for steady income amid uncertainty. See more here.",
      "url": "https://finnhub.io/api/news?id=74188dfc6c054335e28cfe325104cfd59c9ce3309ebc27b0a515b2404736c303"
    }
  }
]